{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:00:01Z","timestamp":1790834401446,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006734","name":"Princeton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM132189"],"award-info":[{"award-number":["R01 GM132189"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000879","name":"Alfred P. Sloan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.chembiol.2023.06.010","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T10:36:14Z","timestamp":1688985374000},"page":"906-919.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Inhibition of nucleolar transcription by oxaliplatin involves ATM\/ATR kinase signaling"],"prefix":"10.1016","volume":"30","author":[{"given":"Misha","family":"Nechay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2023.06.010_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2023.06.010_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2023.06.010_bib3","first-page":"227","article-title":"Cellular and Molecular Pharmacology of Oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.chembiol.2023.06.010_bib4","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/acschembio.7b00553","article-title":"Platinum Binds Proteins in the Endoplasmic Reticulum of S. cerevisiae and Induces Endoplasmic Reticulum Stress","volume":"12","author":"Cunningham","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.06.010_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/cb200279p","article-title":"RNA-Pt Adducts Following Cisplatin Treatment of Saccharomyces cerevisiae","volume":"7","author":"Hostetter","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.06.010_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2023.06.010_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular Mechanisms of Resistance and Toxicity Associated with Platinating Agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.chembiol.2023.06.010_bib8","doi-asserted-by":"crossref","first-page":"11987","DOI":"10.1073\/pnas.1207670109","article-title":"Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile","volume":"109","author":"Park","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.06.010_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.106.110346","article-title":"Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1\u20133 and Multidrug and Toxin Extrusion Family)","volume":"319","author":"Yonezawa","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.chembiol.2023.06.010_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.4291","article-title":"A subset of platinum-containing chemotherapeutic agents kill cells by inducing ribosome biogenesis stress rather than by engaging a DNA damage response","volume":"23","author":"Bruno","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2023.06.010_bib11","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1074\/jbc.M109.074211","article-title":"Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels","volume":"285","author":"Burger","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.06.010_bib12","doi-asserted-by":"crossref","first-page":"111629","DOI":"10.1016\/j.celrep.2022.111629","article-title":"Oxaliplatin disrupts nucleolar function through biophysical disintegration","volume":"41","author":"Schmidt","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2023.06.010_bib13","doi-asserted-by":"crossref","first-page":"18411","DOI":"10.1021\/jacs.9b10319","article-title":"Nucleolar Stress Induction by Oxaliplatin and Derivatives","volume":"141","author":"Sutton","year":"2019","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2023.06.010_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15698\/cst2018.06.139","article-title":"Nucleolar Stress: hallmarks, sensing mechanism and diseases","volume":"2","author":"Yang","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.chembiol.2023.06.010_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nature05842","article-title":"The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks","volume":"447","author":"Kruhlak","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2023.06.010_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ncb3007","article-title":"The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage","volume":"16","author":"Larsen","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2023.06.010_bib17","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.jbc.2021.100633","article-title":"Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin","volume":"296","author":"Sutton","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.06.010_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molcel.2010.09.024","article-title":"The Nucleolus under Stress","volume":"40","author":"Boulon","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.chembiol.2023.06.010_bib19","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1073\/pnas.0402492101","article-title":"The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor","volume":"101","author":"Valdez","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.06.010_bib20","doi-asserted-by":"crossref","first-page":"14417","DOI":"10.1021\/jacs.0c04566","article-title":"Cell- and Polymerase-Selective Metabolic Labeling of Cellular RNA with 2\u2032-Azidocytidine","volume":"142","author":"Wang","year":"2020","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2023.06.010_bib21","doi-asserted-by":"crossref","first-page":"13599","DOI":"10.1038\/ncomms13599","article-title":"A redox mechanism underlying nucleolar stress sensing by nucleophosmin","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2023.06.010_bib22","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.1093\/nar\/gkaa713","article-title":"Recent advances in the nucleolar responses to DNA double-strand breaks","volume":"48","author":"Korsholm","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2023.06.010_bib23","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1158\/0008-5472.CAN-05-1759","article-title":"DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF","volume":"65","author":"Lee","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2023.06.010_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/bi00324a025","article-title":"Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation","volume":"24","author":"Fichtinger-Schepman","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2023.06.010_bib25","article-title":"A new role for cisplatin: probing ribosomal RNA structure","author":"Rijal","year":"2007","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chembiol.2023.06.010_bib26","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1038\/ncomms12856","article-title":"Structure-function insights reveal the human ribosome as a cancer target for antibiotics","volume":"7","author":"Myasnikov","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2023.06.010_bib27","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1039\/C7CC06708A","article-title":"Mapping platinum adducts on yeast ribosomal RNA using high-throughput sequencing","volume":"53","author":"Plakos","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chembiol.2023.06.010_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/cells9020266","article-title":"Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age","volume":"9","author":"Ferreira","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.chembiol.2023.06.010_bib29","doi-asserted-by":"crossref","first-page":"101450","DOI":"10.1016\/j.jbc.2021.101450","article-title":"The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of RNA polymerase I in\u00a0vivo and in\u00a0vitro","volume":"298","author":"Jacobs","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.06.010_bib30","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1091\/mbc.e04-11-0992","article-title":"Dynamic Sorting of Nuclear Components into Distinct Nucleolar Caps during Transcriptional Inhibition","volume":"16","author":"Shav-Tal","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.chembiol.2023.06.010_bib31","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1074\/jbc.M112.411611","article-title":"Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription","volume":"288","author":"Andrews","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.06.010_bib32","doi-asserted-by":"crossref","first-page":"zcaa032","DOI":"10.1093\/narcan\/zcaa032","article-title":"The chemotherapeutic agent\u00a0CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability","volume":"2","author":"Mars","year":"2020","journal-title":"NAR Cancer"},{"key":"10.1016\/j.chembiol.2023.06.010_bib33","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/MCB.21.8.2641-2649.2001","article-title":"A Step Subsequent to Preinitiation Complex Assembly at the Ribosomal RNA Gene Promoter Is Rate Limiting for Human RNA Polymerase I-Dependent Transcription","volume":"21","author":"Panov","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.chembiol.2023.06.010_bib34","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1093\/nar\/gkz518","article-title":"Double-strand breaks in ribosomal RNA genes activate a distinct signaling and chromatin response to facilitate nucleolar restructuring and repair","volume":"47","author":"Korsholm","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2023.06.010_bib35","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cell.2010.04.038","article-title":"An ATM-Dependent Transcriptional Silencing Program is Transmitted Through Chromatin in Cis to DNA Double Strand Breaks","volume":"141","author":"Shanbhag","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.06.010_bib36","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1073\/pnas.1921649117","article-title":"The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning","volume":"117","author":"Bruno","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.06.010_bib37","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.4161\/cc.8.17.9503","article-title":"Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy","volume":"8","author":"Choong","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.chembiol.2023.06.010_bib38","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1093\/nar\/gkn550","article-title":"\u03b3-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin","volume":"36","author":"Kinner","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2023.06.010_bib39","doi-asserted-by":"crossref","first-page":"18631","DOI":"10.1073\/pnas.1422488112","article-title":"Treacher Collins syndrome TCOF1 protein cooperates with NBS1 in the DNA damage response","volume":"111","author":"Ciccia","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.06.010_bib40","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1101\/gad.260703.115","article-title":"A localized nucleolar DNA damage response facilitates recruitment of the homology-directed repair machinery independent of cell cycle stage","volume":"29","author":"van Sluis","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.chembiol.2023.06.010_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41467-019-13981-x","article-title":"Treacle controls the nucleolar response to rDNA breaks via TOPBP1 recruitment and ATR activation","volume":"11","author":"Mooser","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2023.06.010_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tibs.2020.11.002","article-title":"The Hammer and the Dance of Cell Cycle Control","volume":"46","author":"Panagopoulos","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.chembiol.2023.06.010_bib43","doi-asserted-by":"crossref","first-page":"e101005","DOI":"10.15252\/embj.2018101005","article-title":"NBS1 promotes the endonuclease activity of the MRE11-RAD50 complex by sensing CtIP phosphorylation","volume":"38","author":"Anand","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2023.06.010_bib44","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.06.010_bib45","doi-asserted-by":"crossref","first-page":"e98760","DOI":"10.15252\/embj.201798760","article-title":"MST2 kinase suppresses rDNA transcription in response to DNA damage by phosphorylating nucleolar histone H2B","volume":"37","author":"Pefani","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2023.06.010_bib46","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0026-895X(24)12463-7","article-title":"Oxaliplatin-Induced Damage of Cellular DNA","volume":"58","author":"Woynarowski","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.chembiol.2023.06.010_bib47","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, Recognition, and Processing of Cisplatin\u2212DNA Adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.chembiol.2023.06.010_bib48","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1529\/biophysj.107.116996","article-title":"Conformation of DNA GG Intrastrand Cross-Link of Antitumor Oxaliplatin and Its Enantiomeric Analog","volume":"93","author":"Malina","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.chembiol.2023.06.010_bib49","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1021\/ic010790t","article-title":"2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex","volume":"40","author":"Spingler","year":"2001","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.chembiol.2023.06.010_bib50","doi-asserted-by":"crossref","first-page":"38774","DOI":"10.1074\/jbc.M106374200","article-title":"Effects of Spectator Ligands on the Specific Recognition of Intrastrand Platinum-DNA Cross-links by High Mobility Group Box and TATA-binding Proteins\u2217210","volume":"276","author":"Wei","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.06.010_bib51","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1074\/jbc.M105382200","article-title":"MutS Preferentially Recognizes Cisplatin- over Oxaliplatin-modified DNA","volume":"277","author":"Zdraveski","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.06.010_bib52","doi-asserted-by":"crossref","first-page":"16307","DOI":"10.1021\/bi981708h","article-title":"Cisplatin\u2212DNA Adducts Inhibit Ribosomal RNA Synthesis by Hijacking the Transcription Factor Human Upstream Binding Factor","volume":"37","author":"Zhai","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2023.06.010_bib53","doi-asserted-by":"crossref","first-page":"49800","DOI":"10.18632\/oncotarget.10452","article-title":"Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM\/ATR signaling","volume":"7","author":"Quin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2023.06.010_bib54","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1126\/science.aaz4427","article-title":"Partitioning of cancer therapeutics in nuclear condensates","volume":"368","author":"Klein","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.06.010_bib55","article-title":"Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt(II)-induced nucleolar stress","author":"Guerrero","year":"2023","journal-title":"ChemRxiv"},{"key":"10.1016\/j.chembiol.2023.06.010_bib56","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.3413483","article-title":"Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis","volume":"241","author":"Bell","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.06.010_bib57","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/MCB.21.8.2641-2649.2001","article-title":"A step subsequent to preinitiation complex assembly at the ribosomal RNA gene promoter is rate limiting for human RNA polymerase I-dependent transcription","volume":"21","author":"Panov","year":"2001","journal-title":"Mol. Cell Biol."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:43:44Z","timestamp":1762526624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945623001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2451945623001885"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.06.010","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of nucleolar transcription by oxaliplatin involves ATM\/ATR kinase signaling","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}